Immediate Impact

2 by Nobel laureates 2 from Science/Nature 63 standout
Sub-graph 1 of 24

Citing Papers

Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease
2025 StandoutNature
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
2024 Standout
2 intermediate papers

Works of J. Kothari being referenced

Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long-Term Extension of the BENEFIT Study
2013
Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients
2011

Author Peers

Author Last Decade Papers Cites
J. Kothari 93 42 79 300 153 5 422
Basma Sadaka 39 25 94 360 152 11 429
Gail Y. Higgins 111 74 67 287 162 9 491
Laura Lees 167 35 100 247 137 10 449
Clare Nasmyth‐Miller 100 38 27 278 124 11 484
Richard Croy 72 16 53 300 144 9 392
Nauman Siddiqi 81 143 104 139 81 9 456
Diane Lepley 62 35 104 250 151 10 372
Martine Gioud-Paquet 59 101 33 172 117 7 476
RONALD H. KERMAN 66 11 71 340 223 14 502
Arthur J. Matas 43 27 48 312 233 7 477

All Works

Loading papers...

Rankless by CCL
2026